Related Experiment Video
Updated: Aug 6, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
Melatonin hybrids as multifunctional therapeutic agents: A comprehensive review
Elham Khayer Damirchi1, Amin Barani1, Seyyed Mohammad Hamidi1
1Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, 48471-93698, Iran.
Melatonin-based hybrid compounds show promise for treating complex diseases like Alzheimer's and cancer. This drug design strategy enhances therapeutic efficacy and reduces toxicity by combining melatonin with other active molecules.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Design
Background:
- Melatonin is a hormone with antioxidant, anti-inflammatory, and neuroprotective properties.
- Compound hybridization is an emerging strategy to develop novel therapeutics.
- Hybrid molecules aim to improve efficacy and reduce toxicity of individual components.
Purpose of the Study:
- To review the pharmacological assessment and therapeutic potential of melatonin-based hybrid compounds.
- To explore the application of these hybrids in treating complex diseases.
- To highlight the advantages of melatonin hybridization in drug design.
Main Methods:
- Literature review of studies on melatonin-based hybrid compounds.
- Pharmacological evaluation of synthesized hybrid molecules.
- Assessment of therapeutic efficacy in various disease models.
Main Results:
- Melatonin hybrids demonstrate enhanced binding affinity, selectivity, and pharmacokinetic profiles.
- Significant efficacy observed in treating Alzheimer's disease, cancer, and inflammatory disorders.
- Hybridization yields novel structures with improved therapeutic outcomes.
Conclusions:
- Melatonin-based hybrids represent a promising new generation of therapeutic agents.
- Compound hybridization is a valuable strategy for developing advanced treatments.
- These hybrids offer a potent approach for managing complex and challenging diseases.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Drug Therapy
Antianxiety Medications
